|
08:30 - 09:00 |
µî·Ï |
09:00 - 10:10 |
Symposium III : DM & Atherosclerosis ÁÂÀå: ¹Ú¿µ¹è(¼¿ïÀÇ´ë), ¹ÚÁß¿(¿ï»êÀÇ´ë) |
09:00 - 09:20 |
The Effects of Peroxisome proliferator-activated receptor-gamma (PPAR-¥ã) and ?delta (PPAR-¥ä) agonists on human vascular endothelial cells in wound healing model |
ÃÖ¼ºÈñ(¼¿ïÀÇ´ë) |
09:20 - 09:40 |
>Diabetes and vascular dysfunction |
¹ÚÁß¿(¿ï»êÀÇ´ë) |
09:40 - 10:00 |
Vascular calfication and osteoporosis: from clinical observation to genetic models |
ÀÌÀºÁ¤(¼º±Õ°üÀÇ´ë) |
10:00 - 10:10 |
Q & A |
10:10 - 11:10 |
Plenary Lecture
ÁÂÀå: ±è±¤¿ø(¼º±Õ°üÀÇ´ë), À̸í¼÷(¼º½Å¿©´ë) |
10:10 - 10:40 |
Postprandial Hyperlipemia: The Fire Within |
John Rutledge (UC Davis, U.S.A) |
10:40 - 11:10 |
Discovering gene-environment interactions in metabolic syndrome: an epidemiological approach |
Kee Seng Chia (NUS-GIS Centre, Singapore) |
11:10 - 12:40 |
Oral presentation 1
ÁÂÀå: ¹ÚÁ¤ÀÇ(¼º±Õ°üÀÇ´ë), ±Ç¿µ±Ù(¿¬¼¼´ë) |
12:40 - 13:20 |
Luncheon Session: Satellite Symposium
ÁÂÀå: Àå¾ç¼ö(¿¬¼¼ÀÇ´ë) |
12:40 - 13:00 |
Exforge(Amlodipine / Valsartan) Changing the Landscape of BP management |
ÀÌ»óÇÐ(¿¬¼¼ÀÇ´ë) |
13:00 - 13:20 |
Rheology & atherosclerosis |
À̺´±Ç(ÀÎÁ¦ÀÇ´ë) |
13:20 - 13:40 |
Break |
13:40 - 15:30 |
Oral presentation 2
ÁÂÀå: À̹®±Ô(¼º±Õ°üÀÇ´ë), ¹ÚÇý°æ(½Ä¾àû) |
15:30 - 16:00 |
Special Lecture
ÁÂÀå: ÃÖ°æÈÆ(¿¬¼¼¿øÁÖÀÇ´ë) |
15:30 - 16:00 |
Vasa Vasorum Neovascularization in Atherosclerosis |
Pedro R. Moreno (Mount Sinai Medical Center, U.S.A) |
16:00 - 16:20 |
Coffee break |
16:20 - 17:20 |
Symposium IV: Vulnerlable plaque & atherosclerosis ÁÂÀå: Àå¾ç¼ö(¿¬¼¼ÀÇ´ë), ±èÈ¿¼ö(¼¿ïÀÇ´ë) |
16:20 - 16:50 |
Noninvasive Diagnosis of Vulnerable Plaques: Roles of MRI and MDCT |
ÃÖ¿¬Çö(¼º±Õ°üÀÇ´ë) |
16:50 - 17:20 |
Invasive Diagnosis of Vulnerable Plaque: Detection by Virtual Histology IVUS and Optical Coherence Tomography |
Junya Shite(Kobe Univ., Japan) |
17:20 - 17:30 |
Q & A |
17:30 - 17:40 |
½Ã»ó ¹× Æóȸ½Ä |
ÃÖ°æÈÆ È¸Àå´Ô, Àå¾ç¼ö ÇмúÀ§¿øÀå |
|